Veracyte Inc.

Veracyte Inc. delivers genomic diagnostics for thyroid, breast, prostate, lung, and bladder cancers—e.g., Afirma, Prosigna, Decipher, Percepta tests—supporting early detection, surgical sparing, and treatment decisions, backed by partnerships with J&J, Bayer, Loxo, and Acerta.

Headquarters: United States (USA)

Veracyte Inc. Logo
Company Profile
  • Employees: 824
  • HQ: South San Francisco
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
VCYT Veracyte Inc.
Cap: 3.4B | P/E: 112.4
EQUITY NMS USD US92337F1075 Active
📈
Home Login